![Christopher Beattie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Beattie
Offentlig kommunikationskontakt på
BLACKROCK CAPITAL INVESTMENT CORPORATION
Profil
Christopher Beattie is currently working as a Press Contact at BlackRock Capital Investment Corp.
Prior to this, he worked as a Director-Clinical & Regulatory Affairs at Onyvax Ltd. and as a Principal at Xenova Group Plc.
Aktiva positioner av Christopher Beattie
| Företag | Position | Start |
|---|---|---|
| BLACKROCK CAPITAL INVESTMENT CORPORATION | Offentlig kommunikationskontakt | - |
Tidigare kända positioner av Christopher Beattie
| Företag | Position | Slut |
|---|---|---|
Xenova Group Plc
 Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Företagsledare/Principal | - |
Onyvax Ltd.
 Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Develops cancer remedy therapies | Generell Rådgivare | 2012-05-31 |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
4
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Xenova Group Plc
Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
BlackRock Capital Investment Corp
 BlackRock Capital Investment Corp Investment ManagersFinance Operates as a closed-end management investment company | Finance |
Onyvax Ltd.
Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Develops cancer remedy therapies | Commercial Services |
